VOYAGER THERAPEUTICS INC (VYGR) Stock Earnings & Estimates
NASDAQ:VYGR - US92915B1061 - Common Stock
3.36 USD
-0.04 (-1.18%)
3.36 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 40.9M 9.36% | 250.008M 511.27% | 80.001M -68.00% | 30.681M -61.65% | 63.53M 107.07% | 69.276M 9.04% | 112.03M 61.72% | 69.608M -37.87% | 90.137M 29.49% | 175.38M 94.57% | 334M 90.44% | |
| EBITDA YoY % growth | -44.61M 34.81% | 126.455M 383.47% | -75.756M -159.91% | -126.461M -66.93% | -116.583M 7.81% | -117.845M -1.08% | -146.931M -24.68% | -151.98M -3.44% | -151.317M 0.44% | 80.172M 152.98% | 536.83M 569.60% | |
| EBIT YoY % growth | -50.8M 30.98% | 122.014M 340.19% | -80.487M -165.97% | -138.965M -72.65% | -112.02M 19.39% | -128.456M -14.67% | -104.262M 18.83% | -182.884M -75.41% | -195.496M -6.90% | -127.545M 34.76% | 19.588M 115.36% | |
| Operating Margin | -124.21% | 48.80% | -100.61% | -452.93% | -176.33% | -185.43% | -93.07% | -262.73% | -216.89% | -72.72% | 5.86% | |
| EPS YoY % growth | -1.22 35.79% | 3.09 353.28% | -1.13 -136.57% | -2.16 -90.87% | -1.52 29.74% | -1.41 6.73% | -0.48 66.39% | -1.38 -190.59% | -1.20 13.42% | -0.02 98.57% | 1.42 8,463.47% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.53 -231.77% | -0.50 15.47% | -0.46 12.63% | -0.44 22.34% | -0.43 18.34% | -0.47 6.43% |
| Revenue Q2Q % growth | 8.015M -67.46% | 10.748M 71.20% | 8.874M 37.09% | 10.18M 95.77% | 11.45M 42.86% | 9.18M -14.59% |
| EBITDA Q2Q % growth | -28.672M -185.01% | -24.899M 25.82% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -34.218M -148.32% | -32.53M 15.06% | -35.351M -1.90% | -34.17M 6.70% | -31.67M 7.45% | -35.858M -10.23% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.57 -216.67% | -0.54 | -0.03 | -6.33% |
| Q1 2025 Q2Q % growth | -0.53 -165.00% | -0.46 | -0.07 | -15.73% |
| Q4 2024 Q2Q % growth | -0.59 -147.20% | -0.37 | -0.22 | -57.86% |
| Q3 2024 Q2Q % growth | -0.16 72.88% | -0.46 | 0.30 | 65.43% |
| Q2 2024 Q2Q % growth | -0.18 64.71% | -0.42 | 0.24 | 56.91% |
| Q1 2024 Q2Q % growth | -0.20 -106.80% | -0.45 | 0.25 | 55.44% |
| Q4 2023 Q2Q % growth | 1.25 304.92% | -0.29 | 1.54 | 524.68% |
| Q3 2023 Q2Q % growth | -0.59 -231.11% | -0.59 | 0.00 | 0.49% |
| Q2 2023 Q2Q % growth | -0.51 -2.00% | -0.58 | 0.07 | 12.06% |
| Q1 2023 Q2Q % growth | 2.94 625.00% | 0.79 | 2.15 | 273.52% |
| Q4 2022 Q2Q % growth | -0.61 -506.67% | -0.56 | -0.05 | -9.30% |
| Q3 2022 Q2Q % growth | 0.45 167.16% | -0.32 | 0.77 | 239.11% |
| Q2 2022 Q2Q % growth | -0.50 37.50% | -0.32 | -0.18 | -54.39% |
| Q1 2022 Q2Q % growth | -0.56 3.45% | -0.35 | -0.21 | -59.46% |
| Q4 2021 Q2Q % growth | 0.15 134.88% | -0.32 | 0.47 | 146.44% |
| Q3 2021 Q2Q % growth | -0.67 -129.52% | -0.74 | 0.07 | 9.71% |
| Q2 2021 Q2Q % growth | -0.80 -247.83% | -0.73 | -0.07 | -10.08% |
| Q1 2021 Q2Q % growth | -0.58 12.12% | -0.67 | 0.09 | 13.32% |
| Q4 2020 Q2Q % growth | -0.43 -26.47% | -0.58 | 0.15 | 25.40% |
| Q3 2020 Q2Q % growth | 2.27 653.66% | -0.20 | 2.47 | 1,263.66% |
| Q2 2020 Q2Q % growth | -0.23 -179.31% | -0.73 | 0.50 | 68.54% |
| Q1 2020 Q2Q % growth | -0.66 18.52% | -0.81 | 0.15 | 18.21% |
| Q4 2019 Q2Q % growth | -0.34 | -0.82 | 0.48 | 58.71% |
| Q3 2019 Q2Q % growth | -0.41 | -0.77 | 0.36 | 46.88% |
| Q2 2019 Q2Q % growth | 0.29 | -0.77 | 1.06 | 137.78% |
| Q1 2019 Q2Q % growth | -0.81 | 0.59 | -1.40 | -236.19% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 5.2M -82.42% | 10.106M | -4.906M | -48.55% |
| Q1 2025 Q2Q % growth | 6.473M -66.83% | 13.827M | -7.354M | -53.19% |
| Q4 2024 Q2Q % growth | 6.278M -93.03% | 16.909M | -10.631M | -62.87% |
| Q3 2024 Q2Q % growth | 24.629M 433.79% | 12.129M | 12.5M | 103.06% |
| Q2 2024 Q2Q % growth | 29.578M 509.48% | 9.65M | 19.928M | 206.51% |
| Q1 2024 Q2Q % growth | 19.516M -87.03% | 9.603M | 9.913M | 103.23% |
| Q4 2023 Q2Q % growth | 90.061M 6,104.07% | 21.048M | 69.013M | 327.88% |
| Q3 2023 Q2Q % growth | 4.614M -88.77% | 2.966M | 1.648M | 55.56% |
| Q2 2023 Q2Q % growth | 4.853M 593.29% | 1.632M | 3.221M | 197.37% |
| Q1 2023 Q2Q % growth | 150.48M 21,397.14% | 41.82M | 108.66M | 259.83% |
| Q4 2022 Q2Q % growth | -1.5M -105.34% | 4.271M | -5.771M | -135.12% |
| Q3 2022 Q2Q % growth | 41.1M 2,640.00% | 9.604M | 31.496M | 327.95% |
| Q2 2022 Q2Q % growth | 700K -50.00% | 13.041M | -12.341M | -94.63% |
| Q1 2022 Q2Q % growth | 700K -89.23% | 14.705M | -14.005M | -95.24% |
| Q4 2021 Q2Q % growth | 28.1M 332.31% | 14.837M | 13.263M | 89.39% |
| Q3 2021 Q2Q % growth | 1.5M -98.73% | 2.186M | -686K | -31.38% |
| Q2 2021 Q2Q % growth | 1.4M -95.12% | 4.867M | -3.467M | -71.23% |
| Q1 2021 Q2Q % growth | 6.5M -64.09% | 5.523M | 977K | 17.69% |
| Q4 2020 Q2Q % growth | 6.5M -80.12% | 13.584M | -7.084M | -52.15% |
| Q3 2020 Q2Q % growth | 117.8M 477.45% | 38.082M | 79.718M | 209.33% |
| Q2 2020 Q2Q % growth | 28.7M -37.74% | 15.836M | 12.864M | 81.23% |
| Q1 2020 Q2Q % growth | 18.1M 248.08% | 13.817M | 4.283M | 31.00% |
| Q4 2019 Q2Q % growth | 32.7M | 11.144M | 21.556M | 193.43% |
| Q3 2019 Q2Q % growth | 20.4M | 7.792M | 12.608M | 161.81% |
| Q2 2019 Q2Q % growth | 46.1M | 7.789M | 38.311M | 491.86% |
| Q1 2019 Q2Q % growth | 5.2M | 49.248M | -44.048M | -89.44% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.94% | -25.49% | 0.08% | 0.08% |
| Revenue | -17.37% | -55.29% | -22.12% | -39.28% |